7,8-Dihydroxychlorpromazine: (Na+ plus K+)-ATPase inhibition and positive inotropic effect.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000166:cytology; D002746:Chlorpromazine / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000528:radiation effects; D004229:Dithiothreitol / Q000494:pharmacology; D004347:Drug Interactions; D004558:Electric Stimulation; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D006900:Hydroxylation; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008274:Magnesium; D008861:Microsomes / Q000201:enzymology; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium; D011433:Propranolol / Q000494:pharmacology; D011830:Radiation Effects; D012964:Sodium; D013268:Stimulation, Chemical; D014466:Ultraviolet Rays
D010042:Ouabain; D000255:Adenosine Triphosphate; D012964:Sodium; D011433:Propranolol; D000251:Adenosine Triphosphatases; D008274:Magnesium; D007545:Isoproterenol; D011188:Potassium; D004229:Dithiothreitol; D002746:Chlorpromazine